Animal Microbiome Congress 2021 | Kisaco Research

Animal Microbiome Congress 2021 - Join us virtually!

Unlocking the full functional potential of Animal Microbiome research to support commercialization & achieve sustainability goals

VIEW 2021 AGENDA
Virtual Event
24-25 March, 2021

“The program was well-designed and balanced to promote a good discussion across expertise, the sessions were well-chaired and, and there was time for networking”

David Yáñez-Ruiz, Spanish National Research Council

Why Attend

Animal Microbiome Congress will provide the latest clinical data and key content on the commercialisation of animal microbiome research. The global market is forecasted to grow to $9,775 million by 2028 due to demand for innovation from the rapidly growing meat and pet-healthcare industries.

Current research strongly indicates that animal microbiome modulation could greatly improve pet health and increase the meat industry’s productivity, while ensuring that it meets its sustainability targets. Consequently, significant profits can be created by overcoming the obstacles in reproducing animal microbiome research in industry and quicker returns can be obtained by translating the more advanced human microbiome technology to modulate the animal microbiome. However, these commercial rewards can only be realised by steering through tough legal and regulatory obstacles smartly.

Our goal is to support smart interactions between business and academia to enable participants to capitalize on the growing global animal microbiome market.

 

OUR SPEAKERS

 

Antton Alberdi Estibaritz, Ph.D.

Associate Professor
University of Copenhagen

Antton Alberdi Estibaritz, Ph.D.

Associate Professor
University of Copenhagen

Antton Alberdi Estibaritz, Ph.D.

Associate Professor
University of Copenhagen
 

Chris Belnap

CEO and Co-Founder
Resilient Biotics

Chris Belnap

CEO and Co-Founder
Resilient Biotics

Chris Belnap

CEO and Co-Founder
Resilient Biotics
 

Mark Pallen

Professor of Microbial Genomics & Group Leader
University of East Anglia & Quadram Institute

Mark Pallen is a Research Leader at the Quadram Institute and Professor of Microbial Genomics at UEA. His research interests span microbial genomics, metagenomics and bioinformatics, including the chicken gut microbiome. He is director of the MRC Cloud Infrastructure for Microbial Bioinformatics (CLIMB) project.

Mark Pallen

Professor of Microbial Genomics & Group Leader
University of East Anglia & Quadram Institute

Mark Pallen

Professor of Microbial Genomics & Group Leader
University of East Anglia & Quadram Institute

Mark Pallen is a Research Leader at the Quadram Institute and Professor of Microbial Genomics at UEA. His research interests span microbial genomics, metagenomics and bioinformatics, including the chicken gut microbiome. He is director of the MRC Cloud Infrastructure for Microbial Bioinformatics (CLIMB) project.

 

Monika Proszkowiec- Welgarz Ph.D.

Research Molecular Biologist
USDA-ARS

Monika Proszkowiec- Welgarz Ph.D.

Research Molecular Biologist
USDA-ARS

Monika Proszkowiec- Welgarz Ph.D.

Research Molecular Biologist
USDA-ARS
 

Professor Curtis Huttenhower

Associate Professor of Computational Biology and Bioinformatics
Harvard School of Public Health

Talk to me about… your research

Professor Curtis Huttenhower

Associate Professor of Computational Biology and Bioinformatics
Harvard School of Public Health

Professor Curtis Huttenhower

Associate Professor of Computational Biology and Bioinformatics
Harvard School of Public Health

Talk to me about… your research

I am a Professor in Biostatistics at the Harvard T.H. Chan School of Public Health and an Associate Member at the Broad Institute.  I participated extensively in the NIH Human Microbiome Project and co-leads the "HMP2" Center for Characterizing the gut microbial ecosystem in IBD and the Human Microbiome Bioactives Resource.  My  lab focuses on computational methods for functional analysis of microbial communities.  This includes systems biology reconstructions integrating metagenomic, metatranscriptomic, and other microbial community 'omics, the human microbiome in autoimmune disease such as IBD, and its potential as a biomarker and route for therapeutic intervention.

 

Talk to me about…something people may not know about you

I'm a happy kitty parent, most recently of two new kittens who (like human babies) have as yet to learn to sleep through the night. I wish I had as much energy as they do!

 

Devan Compart

Ruminant Feed Additive Research Specialist
Land O’Lakes, Inc.

Devan Compart

Ruminant Feed Additive Research Specialist
Land O’Lakes, Inc.

Devan Compart

Ruminant Feed Additive Research Specialist
Land O’Lakes, Inc.
 

J.M. Geremia, Ph.D.

Vice President & Founder
Midori USA, Inc.

J.M. Geremia, Ph.D.

Vice President & Founder
Midori USA, Inc.

J.M. Geremia, Ph.D.

Vice President & Founder
Midori USA, Inc.
 

Dipti Pitta

Assistant Professor in Ruminant Nutrition and Microbiology
University of Pennsylvania – School of Veterinary Medicine

Dipti Pitta

Assistant Professor in Ruminant Nutrition and Microbiology
University of Pennsylvania – School of Veterinary Medicine

Dipti Pitta

Assistant Professor in Ruminant Nutrition and Microbiology
University of Pennsylvania – School of Veterinary Medicine
 

Dr Emily Stein

Chief Executive Officer & Co-Founder
TEEF!

Dr Emily Stein

Chief Executive Officer & Co-Founder
TEEF!

Dr Emily Stein

Chief Executive Officer & Co-Founder
TEEF!
 

Jacob Lum Ph.D.

Vice President of Technical Services
Euroduna Americas

Jacob Lum Ph.D.

Vice President of Technical Services
Euroduna Americas

Jacob Lum Ph.D.

Vice President of Technical Services
Euroduna Americas
 

Dr Jenny Bailey

Co-Founder and CEO
Ferryx

Dr Jenny Bailey

Co-Founder and CEO
Ferryx

Dr Jenny Bailey

Co-Founder and CEO
Ferryx
 

John Gregg

CEO
BalinBac Therapeutics

John Gregg

CEO
BalinBac Therapeutics

John Gregg

CEO
BalinBac Therapeutics
 

Greg Sunvold

Director of Nutrition
Cool Springs International, LLC

With over 25 years of pet food industry experience and over 200 scientific publications, Dr. Greg Sunvold at Cool Springs International is responsible for implementing nutritional innovations in hundreds of pet food products.  Additionally, Dr. Sunvold founded Microbiome Health, LLC, a company focused on applying innovative microbiome technologies into pet supplements.  

Greg Sunvold

Director of Nutrition
Cool Springs International, LLC

Greg Sunvold

Director of Nutrition
Cool Springs International, LLC

With over 25 years of pet food industry experience and over 200 scientific publications, Dr. Greg Sunvold at Cool Springs International is responsible for implementing nutritional innovations in hundreds of pet food products.  Additionally, Dr. Sunvold founded Microbiome Health, LLC, a company focused on applying innovative microbiome technologies into pet supplements.  

 

Mike Kogut

Research Microbiologist
USDA-ARS

Mike Kogut

Research Microbiologist
USDA-ARS

Mike Kogut

Research Microbiologist
USDA-ARS
 

Craig Thomson

Partner & Patent Attorney
HGF Limited

Craig has considerable experience in providing pragmatic, commercially focused advice to a wide-range of clients and in relation to biotechnological and pharmaceutical fields.  As well as patent drafting and prosecution, Craig advises on the development of company-wide IP strategies, preparing for or carrying out funding/acquisition due diligence, and advising on aggressive/defensive strategies in relation to third party IP. He has a particular interest in inventions relating to the microbiome, including bacteriophage.

Craig Thomson

Partner & Patent Attorney
HGF Limited

Craig Thomson

Partner & Patent Attorney
HGF Limited

Craig has considerable experience in providing pragmatic, commercially focused advice to a wide-range of clients and in relation to biotechnological and pharmaceutical fields.  As well as patent drafting and prosecution, Craig advises on the development of company-wide IP strategies, preparing for or carrying out funding/acquisition due diligence, and advising on aggressive/defensive strategies in relation to third party IP. He has a particular interest in inventions relating to the microbiome, including bacteriophage.

 

Morten T. Limborg, Ph.D.

Associate Professor
University of Copenhagen

Morten T. Limborg, Ph.D.

Associate Professor
University of Copenhagen

Morten T. Limborg, Ph.D.

Associate Professor
University of Copenhagen
 

Phil Elkins

Ruminant Veterinary Consultant & Director
Moo Vet Consultancy

Phil Elkins

Ruminant Veterinary Consultant & Director
Moo Vet Consultancy

Phil Elkins

Ruminant Veterinary Consultant & Director
Moo Vet Consultancy
 

Ryan Honaker PhD

Director of Microbiology
NomNomNow

Ryan Honaker PhD

Director of Microbiology
NomNomNow

Ryan Honaker PhD

Director of Microbiology
NomNomNow
 

Scott Carter

Vice President Microbials Business
Phibro Animal Health

Scott Carter

Vice President Microbials Business
Phibro Animal Health

Scott Carter

Vice President Microbials Business
Phibro Animal Health
 

Sherry Layton

CSO
BV Science

Sherry Layton

CSO
BV Science

Sherry Layton

CSO
BV Science
 

Dr Simon Doherty

Senior Lecturer in Animal Health and Welfare
Queens University Belfast

Dr Simon Doherty

Senior Lecturer in Animal Health and Welfare
Queens University Belfast

Dr Simon Doherty

Senior Lecturer in Animal Health and Welfare
Queens University Belfast
 

Professor, Dr. Thomas Clavel

Microbiome Researcher
University Hospital of RWTH Aachen

The main focus of our research is the study of intestinal microbiomes (the communities of microorganisms, their genomes, and surrounding environmental factors in the gut). Because intestinal microorganisms have a major impact on the physiology of their host, it is important to investigate and understand their diversity and functions. We focus primarily on the human, pig, and mouse gut microbiomes because of their relevance for health-related issues.

Professor, Dr. Thomas Clavel

Microbiome Researcher
University Hospital of RWTH Aachen

Professor, Dr. Thomas Clavel

Microbiome Researcher
University Hospital of RWTH Aachen

The main focus of our research is the study of intestinal microbiomes (the communities of microorganisms, their genomes, and surrounding environmental factors in the gut). Because intestinal microorganisms have a major impact on the physiology of their host, it is important to investigate and understand their diversity and functions. We focus primarily on the human, pig, and mouse gut microbiomes because of their relevance for health-related issues. In particular, we are interested in describing the taxonomic diversity and evolution of gut bacteria thanks to the use of culture-based and sequencing approaches. 

 

Timothy Hackman

Assistant Professor
University of California, Davis

Timothy Hackman

Assistant Professor
University of California, Davis

Timothy Hackman

Assistant Professor
University of California, Davis
 

Cornelia Hüttinger

Group Leader Regulatory Affairs
Klifovet AG

Cornelia Hüttinger

Group Leader Regulatory Affairs
Klifovet AG

Cornelia Hüttinger

Group Leader Regulatory Affairs
Klifovet AG
 

Jane A.Z. Leedle, Ph.D.

President
JL Microbiology, Inc

Jane A.Z. Leedle, Ph.D.

President
JL Microbiology, Inc

Jane A.Z. Leedle, Ph.D.

President
JL Microbiology, Inc
 

Claire Smith

Associate
Anterra Capital

Claire is an Associate at Anterra Capital. Prior to joining Anterra, she was the Chief of Staff at Crestovo, a biotech start-up developing microbiome-based therapies for infectious diseases. Before that, she worked as a consultant at ClearView Healthcare Partners, where she advised pharmaceutical and biotech clients on a variety of growth strategy topics. She graduated from the Massachusetts Institute of Technology with Bachelor of Science degrees in biological engineering and management science.

Claire Smith

Associate
Anterra Capital

Claire Smith

Associate
Anterra Capital

Claire is an Associate at Anterra Capital. Prior to joining Anterra, she was the Chief of Staff at Crestovo, a biotech start-up developing microbiome-based therapies for infectious diseases. Before that, she worked as a consultant at ClearView Healthcare Partners, where she advised pharmaceutical and biotech clients on a variety of growth strategy topics. She graduated from the Massachusetts Institute of Technology with Bachelor of Science degrees in biological engineering and management science.

 

Sharon Huws

Professor in Animal Science and Microbiology
Queen's University Belfast

Sharon Huws

Professor in Animal Science and Microbiology
Queen's University Belfast

Sharon Huws

Professor in Animal Science and Microbiology
Queen's University Belfast
 

Dr Steven Theriault

CEO & CSO
Cytophage Technologies Inc.

Dr Steven Theriault

CEO & CSO
Cytophage Technologies Inc.

Dr Steven Theriault

CEO & CSO
Cytophage Technologies Inc.
 

Dr Diwakar Vyas

Assistant Professor
University of Florida

Dr Diwakar Vyas

Assistant Professor
University of Florida

Dr Diwakar Vyas

Assistant Professor
University of Florida
 

Brian Oakley

Professor
Western University of Health Sciences

I am a microbial ecologist interested in tackling important problems at the interface of basic and applied research.  The revolution in high-throughput DNA sequencing has conclusively demonstrated the importance of microbial communities for life on earth.

Brian Oakley

Professor
Western University of Health Sciences

Brian Oakley

Professor
Western University of Health Sciences

I am a microbial ecologist interested in tackling important problems at the interface of basic and applied research.  The revolution in high-throughput DNA sequencing has conclusively demonstrated the importance of microbial communities for life on earth.  Microbial ecology cuts across many fields and I have applied the tools and techniques of microbial ecology to disciplines ranging from oceanography to human and animal health.  My graduate training combined classical and microbial ecology but I only considered myself a microbiologist after working in the Microbiology Department of the University of Washington, the Fred Hutchinson Cancer Research Center, and the University of Warwick.  Four years as a research microbiologist with the USDA Agricultural Research Service gave me first-hand knowledge of the poultry industry and a chance to apply the tools and techniques of microbial ecology to veterinary microbiology.  Most of the current focus of my research is on the poultry microbiome and its relationships to food safety, infectious disease, and poultry nutrition.  Our standard toolkit combines field work with classical microbiology, microscopy, quantitative PCR, high-throughput 16S rRNA sequencing, metagenomics, and associated bioinformatics.  We are currently funded through several intramural mechanisms, extramural grants, and industry partnerships.

 

Dr Laura Peachey

Lecturer in Veterinary Parasitology
University of Bristol

Dr Laura Peachey

Lecturer in Veterinary Parasitology
University of Bristol

Dr Laura Peachey

Lecturer in Veterinary Parasitology
University of Bristol
 

Alexander Jaramillo Torres

Associated Researcher
Norwegian University of Life Sciences

Alexander Jaramillo Torres

Associated Researcher
Norwegian University of Life Sciences

Alexander Jaramillo Torres

Associated Researcher
Norwegian University of Life Sciences
 

Elizabeth Santin

Vice President, Research and Development
Jefo

Elizabeth Santin

Vice President, Research and Development
Jefo

Elizabeth Santin

Vice President, Research and Development
Jefo
 

Yemi Adesokan

CSO
GNUbiotics

Yemi Adesokan is Chief Scientific Officer and Co-Founder at Gnubiotics SA,  a Lausanne, Switzerland biotech company pioneering the development of Human Milk Oligosacchrides (HMOs) for infants and adults as well as Animal Milk Oligosaccharides (AMOs) for companion animals.  Yemi has been recognized for his innovative and pioneering work with awards such as the Boston Business Journal 40 under 40 award and the  MIT Technology Review’s annual list of 35 top global innovators under the age of 35 TR35.

Yemi Adesokan

CSO
GNUbiotics

Yemi Adesokan

CSO
GNUbiotics

Yemi Adesokan is Chief Scientific Officer and Co-Founder at Gnubiotics SA,  a Lausanne, Switzerland biotech company pioneering the development of Human Milk Oligosacchrides (HMOs) for infants and adults as well as Animal Milk Oligosaccharides (AMOs) for companion animals.  Yemi has been recognized for his innovative and pioneering work with awards such as the Boston Business Journal 40 under 40 award and the  MIT Technology Review’s annual list of 35 top global innovators under the age of 35 TR35. Yemi has a PhD in Chemistry from the University of California, Irvine and completed a post-doctoral fellowship in Genetics with George Church at Harvard Medical School.

 

 

Dr. Radhika Bongoni

Head of Business Development
Baseclear

Dr. Radhika Bongoni

Head of Business Development
Baseclear

Dr. Radhika Bongoni

Head of Business Development
Baseclear

The Virtual Experience

Top 10 benefits

- Tailor Your Agenda 

- More Audience Participation

- Improved Audience Visibility 

- On-Demand Content

- High Quality Speakers 

- More Networking Opportunities 

- Save Time & Money 

- Increased Content 

- More insights 

- Business Development Opportunities - Talk to our team to find out out more [email protected].

Platform Preview

The Agenda

Download the 2021 agenda here.

Agenda released for the Animal Microbiome Congress 2021! Simply fill in this form and we'll send you a PDF version immediately. We need some information to know where to send the file and how to address our email to you.

Download Agenda

Conference Packages

Sending Your Team? Group Discounts Available!

Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates

Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off

If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920

We accept the following cards through Stripe:
Saturday, February 27, 2021 to Friday, March 26, 2021
Tier One: Academics & Emerging
$399
Standard pricing
Academics
Emerging companies
Saturday, February 27, 2021 to Friday, March 26, 2021
Tier Two: Industry & Service Providers
$899
Standard pricing
Preparing registration...

Resources

Download Resource

Gold Event Partner

Silver Event Partner

Event Partners

Media Partners

About Kisaco Research

Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.

Meet industry peers that will help build a career-changing network for life.

Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

Invest both in your company growth and your own personal development by signing up to one of our events and get started.

Contact Us

Other events you might be interested in:

Animal Microbiome & Nutritional Health USA 2020

AH Europe 2021